Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
0(0%)
Results Posted
15%(2 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_1
3
17%
Ph not_applicable
2
11%
Ph phase_2
6
33%
Ph phase_3
3
17%
Ph phase_4
3
17%

Phase Distribution

3

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
3(17.6%)
Phase 2Efficacy & side effects
6(35.3%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
3(17.6%)
N/ANon-phased studies
2(11.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(13)
Terminated(2)
Other(3)

Detailed Status

Completed13
unknown3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (17.6%)
Phase 26 (35.3%)
Phase 33 (17.6%)
Phase 43 (17.6%)
N/A2 (11.8%)

Trials by Status

unknown317%
completed1372%
terminated211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04080895Phase 1

Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects

Terminated
NCT00131703Phase 3

Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women

Completed
NCT05550909Phase 2

Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali

Completed
NCT05471544Phase 3

Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan

Unknown
NCT05478954Phase 4

Chemoprevention Efficacy Study in Burkina Faso

Unknown
NCT05354258Not Applicable

Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children

Unknown
NCT00356824

Relationship Between HIV and Malaria in Ugandan Children

Completed
NCT02696954Phase 1

Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects

Terminated
NCT01955382Phase 2

Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria

Completed
NCT00132548Phase 3

A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children

Completed
NCT02831023Phase 2

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Completed
NCT00323622Phase 2

Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine

Completed
NCT00261222Phase 2

Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso

Completed
NCT00563914Phase 1

A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated Malaria

Completed
NCT00445796Phase 4

Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance

Completed
NCT00137514Phase 4

Chloroquine and Amodiaquine for Treatment of Malaria in Children

Completed
NCT00354380Phase 2

Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study

Completed
NCT00127998Not Applicable

Antimalarial Drug Resistance in Mali

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18